Brain inflammatory cascade controlled by gut-derived molecules

Wekerle, Hartmut

doi:10.1038/d41586-018-05113-0

NEWS AND VIEWS
16 May 2018

Brain inflammatory cascade controlled by gut-derived molecules

Metabolite molecules produced by the gut’s microbes activate immune cells in the brain called microglia, which signal to astrocyte cells to mediate responses to inflammation in the central nervous system.

Hartmut Wekerle⁰

Hartmut Wekerle
1. Hartmut Wekerle is at the Max Planck Institute of Neurobiology, D-82152 Martinsried, Germany.
View author publications

You can also search for this author in PubMed Google Scholar

Access through your institution

Buy or subscribe

Some immunologists regard the central nervous system (CNS) as a no-man’s-land, avoided by immune cells and therefore uninteresting. But, in fact, the CNS has a vigorous immune potential that remains dormant in normal conditions but is awakened after injury. The switch that controls the brain’s immune microenvironment involves non-neuronal cells called glia — not only microglia, which are sometimes called the immune cells of the CNS, but also multifunctional cells called astrocytes¹. In a paper in Nature, Rothhammer et al.² describe how these two glial cell types communicate on a molecular level to influence inflammation in the CNS, and show that this interaction is controlled remotely by microbes that inhabit the gut.

Access options

Access through your institution

Buy article

Get time limited or full article access on ReadCube.

$32.00

Buy

All prices are NET prices.

Nature 557, 642-643 (2018)

doi: https://doi.org/10.1038/d41586-018-05113-0

References

Salter, M. W. & Stevens, B. Nature Med. 23, 1018–1027 (2017).
Article PubMed Google Scholar
Rothhammer, V. et al. Nature 557, 724–728 (2018).
Article Google Scholar
Quintana, F. J. et al. Nature 453, 65–71 (2008).
Article PubMed Google Scholar
Veldhoen, M. et al. Nature 453, 106–109 (2008).
Article PubMed Google Scholar
Okey, A. B., Riddick, D. S. & Harper, P. A. Trends Pharmacol. Sci. 15, 226–232 (1994).
Article PubMed Google Scholar
Rothhammer, V. et al. Nature Med. 22, 586–597 (2016).
Article PubMed Google Scholar
Liddelow, S. A. et al. Nature 541, 481–487 (2017).
Article PubMed Google Scholar
Stockinger, B., Di Meglio, P., Gialitakis, M. & Duarte, J. H. Annu. Rev. Immunol. 32, 403–432 (2014).
Article PubMed Google Scholar
Veldhoen, M. & Brucklacher-Waldert, V. Nature Rev. Immunol. 12, 696–708 (2012).
Article PubMed Google Scholar
Lassmann, H. & Wekerle, H. in McAlpine’s Multiple Sclerosis 4th edn (eds Compston, A. et al.) 557–600 (Churchill Livingstone, 2006).
Google Scholar
Sofroniew, M. V. Neuroscientist 20, 160–172 (2014).
Article PubMed Google Scholar
Monaco, M. C. G. & Major, E. O. Front. Immunol. 6, 159 (2015).
Article PubMed Google Scholar
Li, Q. & Barres, B. A. Nature Rev. Immunol. 18, 225–242 (2018).
Article PubMed Google Scholar
Neumann, H. Glia 36, 191–199 (2001).
Article PubMed Google Scholar
Sampson, T. R. & Mazmanian, S. K. Cell Host Microbe 17, 565–576 (2015).
Article PubMed Google Scholar
Erny, D. et al. Nature Neurosci. 18, 965–977 (2015).
Article PubMed Google Scholar
Riemann-Lorenz, K. et al. PLoS ONE 11, e0165246 (2016).
Article PubMed Google Scholar